• Study on Chemotherapy with Cisplatin, Fluorouracil, and Docetaxel for Patients with Locally Advanced Squamous Cell Carcinoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    France
  • Study on the Safety and Effectiveness of SYD-101 Eye Drops with Atropine Sulfate Monohydrate for Treating Myopia in Children

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Slovakia
  • Study on the Effectiveness and Safety of Finerenone for Adults with Non-Diabetic Chronic Kidney Disease

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria Czechia Denmark Greece Hungary +3
  • Study of Sotorasib Alone and Combined with Pembrolizumab in Adult Patients with Advanced Solid Tumors Having KRAS p.

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium France Greece Hungary Portugal +2
  • Study on the Safety and Tolerability of Nebulised Sodium Nitrite Formulations in Patients with Non-Cystic Fibrosis Bronchiectasis and Pseudomonas Aeruginosa

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Bulgaria Poland Romania
  • Study on Afamelanotide and NB-UVB Light for Vitiligo Treatment in Patients with Vitiligo

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Italy
  • Study on Imaging Lung Aspergillosis Using Gallium-68 Deferoxamine for Patients with Pulmonary Aspergillosis

    Not recruiting

    2 1 1 1
    The Netherlands
  • Study on Ribociclib, Topotecan, and Temozolomide for Children and Young Adults (12 months – 21 years) with Relapsed or Refractory Neuroblastoma and Solid Tumors

    Not recruiting

    1 1 1 1
    Czechia Denmark France Germany Hungary Italy +1
  • Study on Long-Term Safety of Cendakimab for Adults and Adolescents with Eosinophilic Esophagitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Germany Italy Poland Portugal +1
  • Study of Durvalumab, Tremelimumab, and Lenvatinib with TACE for Patients with Liver Cancer (Hepatocellular Carcinoma)

    Not recruiting

    3 1 1 1
    Belgium France Germany Italy Portugal Spain

powered by